The ViennaLab NGS Assays employ target enrichment by either amplicon-based or hybridization capture techniques to optimally fulfill the needs of different applications.

Next Generation Sequencing (NGS) has revolutionized many areas in science and healthcare, ranging from a better understanding of hereditary diseases and cancer, and implications in personalized medicine to improved taxonomic classification of microbial species.
Illumina NGS technologies produce millions of short sequences that require complex analysis to assemble all these pieces together and harness its full potential.

NGS analysis can be a challenging task and as extensive support for all our ViennaLab products is important for us, for our NGS products, this includes troubleshooting the experimental library prep as well as help with the bioinformatic analysis.